Journals / Ankara Medical Journal / 2019 / Cilt: 19 - Sayı: 2

What is The Success Rate of Patients Using Warfarin in Maintaining Their Target International Normalized Ratio Levels?

Varfarin Kullanan Hastaların Hedef Uluslararası Normalleştirilmiş Oran Başarısı ne Kadar İyi?

Pages
366–374
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

New policies and programs should be developed to protect the targetInternational Normalized Ratio levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Patients using warfarin, are also referred to emergency departments when they have anemergency.
📊
Key Findings & Data:The purpose of this study was to demonstrate patient success in maintainingInternational Normalized Ratio by investigating spot International Normalized Ratio levels of patientsusing warfarin who were admitted to emergency services.Materials and Methods: Our study is survey study.
💡
Conclusion & Impact:New policies and programs should be developed to protect the targetInternational Normalized Ratio levels.
🔬Design:Survey & Empirical Study
📍Scope:2071 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Patients using warfarin, are also referred to emergency departments when they have anemergency. When a patient using warfarin presented to the emergency departments to be able toestimate the possible level of International Normalized Ratio can help in making an emergencytreatment plan. The purpose of this study was to demonstrate patient success in maintainingInternational Normalized Ratio by investigating spot International Normalized Ratio levels of patientsusing warfarin who were admitted to emergency services.Materials and Methods: Our study is survey study. Among 2071 patients, 129 patients using warfarindue to non‐valvular causes who were admitted to the emergency departments for warfarin‐unrelatedreasons and who met the inclusion criteria were included in the study.Results: 41.80% of the participants had International Normalized Ratio values within the therapeuticrange. It was shown that warfarin‐related bad experiences and having training did not affect whetherInternational Normalized Ratio was within the therapeutic range or not.Conclusion: Patients using warfarin are unsuccessful in maintaining their target InternationalNormalized Ratio levels. New policies and programs should be developed to protect the targetInternational Normalized Ratio levels.

Özet

Amaç: Varfarin kullanan hastalar, acil durumları olduğunda acil servislere başvururlar. Varfarin kullanan bir hasta acil servise başvurduğundaolası Uluslararası Normalize Oran düzeyini tahmin edebilmek acil tedavi planının yapılmasına yardımcı olabilir. Bu çalışmada acile başvuran ve varfarin kullanan hastaların o anki spot Uluslararası Normalize Oran düzeyleri incelenerek hastaların Uluslararası Normalize Oran kontrolündeki başarılarının gösterilmesi amaçlandı. Materyal ve Metot: Çalışmamız bir anketçalışmasıdır. 2071 hastadan non valvüler nedenli varfarin kullanan, varfarin ilişkisiz bir nedenden dolayı acil servise başvuran ve dahil etme kriterlerini karşılayan 129 hasta çalışmaya kabul edildi. Bulgular: Katılımcıların % 41,80’inin Uluslararası Normalize Oran’ı terapotik aralıktaydı. Uluslararası Normalize Oranın terapotik aralıkta olup olmamasında varfarin ilişkili kötü tecrübelerin ve eğitim almış olmanın etkisinin olmadığı gösterildi.Sonuç: Hastalar hedef Uluslararası Normalize Oran düzeylerini korumada başarısızdır. Hedef Uluslararası Normalize Oranı korumak için yeni politikalar ve programlar geliştirilmelidir.

🔖

Cite This Article

ŞAHİN, S., ŞAN, İ., TEMREL, T. A. (2022). What is The Success Rate of Patients Using Warfarin in Maintaining Their Target International Normalized Ratio Levels?. Ankara Medical Journal, Cilt: 19 - Sayı: 2, 366–374. https://ajindex.com/articles/441922

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Joppa SA, Salciccioli J, Adamski J, Patel S, Wysokinski W, McBane R. Review A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring. Reversal Agents, J. Clin. Med. 2018, 7, 29 (doi:10.3390/jcm7020029
  2. Levine M, Pizon AF, Padilla‐Jones A, Ruha, AM. Warfarin Overdose: A 25‐Year Experience. J. Med. Toxicol. (2014) 10:156–164 (doi: 10.1007/s13181‐013‐0378‐8
  3. Funk DM. Coagulation assays and anticoagulant monitoring. American Society of Hematology, Hematology (2012) 460‐5 4. Wen MS, Lee MM. Warfarin Pharmacogenetics: New Life for an Old Drug. Acta Cardiol Sin 2013;29:235‐42 5. 5‐Garcia DA, Crowther M. Reversal of Warfarin Case‐Based Practice Recommendations. Circulation 2012 Jun 12;125(23):2944‐7. (doi:10.1161/CIRCULATIONAHA.111.081489
  4. Holbrook A, Schulman S, Witt DM et al. Evidence‐Based Management of Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. CHEST 2012; 141(2)(Suppl):e152S– e184S 7. Keeling D, Baglin T, Tait C et al. Guidelines on oral anticoagulation with warfarin – fourth Edition. British Journal of Haematology, 2011;154(3):311–24 (doi:10.1111/j.1365‐2141.2011.08753.x
  5. Rolfe S, Papadopoulos S, Cabral PK. Controversies of Anticoagulation Reversal in Life‐ Threatening Bleeds. Journal of Pharmacy Practice 23(3):217‐25 (doi: 10.1177/0897190010362168
  6. Pirmohamed M. Warfarin: almost 60 years old and still causing problems. British Journal of Clinical Pharmacology 2006; 62: 509‐11 (doi:10.1111/j.1365‐2125.2006.02806.x
  7. Farinola N, Caughey GE, Bell JS, Johns S, Hauta‐aho M, Shakib S. Influence of stroke and bleeding risk on prescribing of oral anticoagulants in older in patients; has the availability of direct oral anticoagulants changed prescribing? Therapeutic Advances in Drug Safety, 2018; 9(2): 113–21 (doi: 10.1177/2042098617747835
  8. Gokcal E, Pasi M, Fisher M, Gurol ME. Atrial Fibrillation for the Neurologist: Preventing both Ischemic and Hemorrhagic Strokes. Current Neurology and Neuroscience Reports 2018; 18(2):6 (
  9. Smith DE, Xuereb CB, Pattison HM, Lip GYH, Lane D. STRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT). BMC Cardiovascular Disorders 2010; 10:21 (
  10. Roskell NS, Samuel M